Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Mid-dose program (144 mg total) With 144 mg across three months, the mid-dose program supports a higher weekly dose
Consistent release of medication for optimal results
Synergy of CJC-1295 and Ipamorelin The synergy of combining CJC-1295 with Ipamorelin lies in the two different but complementary mechanisms: CJC-1295 1 gives sustained baseline elevation of GH/IGF-1 (via GHRH receptor stimulation)
The most frequently reported adverse effects of tirzepatide are gastrointestinal in nature, reflecting its mechanism of action on GLP-1 receptors which slow gastric emptying and promote satiety
US$ 29.71
US$ 24.07
US$ 20.69
US$ 22.10
